Pharmaceutical Market in Australia
This project identifies and studies two competition-law & -policy areas of issues in the pharmaceutical market in Australia: a lack of competition law cases and insufficient competition in the pharmaceutical sector in Australia.
Pharmaceuticals, most notably patented pharmaceuticals, are expensive in Australia. One of the reasons is that the current law and policy tend to favour and overprotect patented drugs over the generics. This overprotection of patented drugs leads to a lack of competition to the detriment of consumers and the Australian economy reflected in higher prices.